Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same

Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same

US Patent 10428059 · Granted Oct 1, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glutamate transporter activators and methods using same2024
Methods of treating or preventing an attention disorder, cognitive disorder, and2023
PXR agonists and uses thereof for gut barrier dysfunction treatment and preventi2023
Glutamate transporter activators and methods using same2022
Compounds and methods of treating or ameliorating an IL-1R-mediated disease or d2022
Compounds and methods of treating or ameliorating an IL-1R-mediated disease or d2022
D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease2022
Treatments for attention and cognitive disorders, and for dementia associated wi2020
D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease2020
Compositions useful in treating brain-related diseases or disorders and methods 2019
Treatments for attention and cognitive disorders, and for dementia associated wi2018
D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease2017